Bristol-Myers Squibb Company (BVL:BMY)

Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
53.06
0.00 (0.00%)
At close: Feb 18, 2026
Market Cap407.19B -8.5%
Revenue (ttm)162.13B -0.2%
Net Income23.73B
EPS11.64
Shares Outn/a
PE Ratio17.16
Forward PE9.51
Dividend8.75 (16.50%)
Ex-Dividend DateJan 2, 2026
Volumen/a
Average Volumen/a
Openn/a
Previous Close53.06
Day's Rangen/a
52-Week Range42.38 - 56.00
Betan/a
RSI78.28
Earnings DateFeb 5, 2026

About BVL:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat ... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 32,500
Stock Exchange Lima Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements